Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $7.11 million. The enterprise value is $806,092.

Market Cap	7.11M
Enterprise Value	806,092

Important Dates

The next estimated earnings date is Thursday, March 19, 2026, after market close.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

PCSA has 2.27 million shares outstanding. The number of shares has increased by 669.62% in one year.

Current Share Class	2.27M
Shares Outstanding	2.27M
Shares Change (YoY)	+669.62%
Shares Change (QoQ)	+205.25%
Owned by Insiders (%)	0.89%
Owned by Institutions (%)	17.46%
Float	2.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.14
P/TBV Ratio	1.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.76

Current Ratio	3.76
Quick Ratio	3.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -270.74% and return on invested capital (ROIC) is -168.65%.

Return on Equity (ROE)	-270.74%
Return on Assets (ROA)	-129.94%
Return on Invested Capital (ROIC)	-168.65%
Return on Capital Employed (ROCE)	-223.21%
Weighted Average Cost of Capital (WACC)	10.45%
Revenue Per Employee	n/a
Profits Per Employee	-$1.29M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.68% in the last 52 weeks. The beta is 1.13, so PCSA's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	-78.68%
50-Day Moving Average	4.71
200-Day Moving Average	5.97
Relative Strength Index (RSI)	41.26
Average Volume (20 Days)	88,520

Short Selling Information

The latest short interest is 98,000, so 4.33% of the outstanding shares have been sold short.

Short Interest	98,000
Short Previous Month	3.45M
Short % of Shares Out	4.33%
Short % of Float	4.80%
Short Ratio (days to cover)	0.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.02M
Pretax Income	-12.93M
Net Income	-12.93M
EBITDA	-13.02M
EBIT	-13.02M
Earnings Per Share (EPS)	-$16.58

Balance Sheet

The company has $6.31 million in cash and n/a in debt, with a net cash position of $6.31 million or $2.78 per share.

Cash & Cash Equivalents	6.31M
Total Debt	n/a
Net Cash	6.31M
Net Cash Per Share	$2.78
Equity (Book Value)	5.83M
Book Value Per Share	2.76
Working Capital	4.84M

Cash Flow

Operating Cash Flow	-10.73M
Capital Expenditures	n/a
Free Cash Flow	-10.73M
FCF Per Share	-$4.74

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-669.62%
Shareholder Yield	-669.62%
Earnings Yield	-181.79%
FCF Yield	-150.85%

Analyst Forecast

The average price target for PCSA is $25.00, which is 696.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	696.18%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 17, 2025. It was a reverse split with a ratio of 1:25.

Last Split Date	Dec 17, 2025
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1